Quest Diagnostics Incorporated (NYSE: DGX) reported a 40% dip in earnings for the first quarter of 2020 due to lower revenue and higher costs and expenses. The company has withdrawn its guidance for the full year 2020 due to the impact of the COVID-19 pandemic.
The pandemic is likely to impact the company’s ability to comply with applicable financial covenants, beginning as early as the end of the second quarter. The company has been in advanced discussions with its lead lender regarding an amendment to certain financial covenants of its unsecured revolving credit facility.
Visa Inc. (NYSE: V) reported first quarter 2023 earnings results today. Net revenues grew 12% year-over-year to $7.9 billion. GAAP net income rose 6% to $4.2 billion while EPS grew
Intel Corporation (NASDAQ: INTC) Thursday reported a decline in adjusted earnings and revenues for the fourth quarter. The semiconductor giant also provided guidance for the first quarter of 2023. Fourth-quarter
Shares of McCormick & Company Inc. (NYSE: MKC) were down over 5% on Thursday after the company missed expectations on its fourth quarter 2022 results and provided a lower-than-expected earnings